Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
20
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Fisher Andrew | General Counsel | 30 | $0 | $1.97M | 2025-10-07 |
| Austwick Michael | Director | 10 | $0 | $148.3K | 2025-10-07 |
| Brady James Aloysius | Director | 14 | $0 | $10.8K | 2025-10-07 |
| Deschamps Lisa | Director | 21 | $0 | $150.1K | 2025-10-07 |
| Rickard Kathleen A. | Chief Medical Officer | 72 | $0 | $5.68M | 2025-10-07 |
| Cunningham Kenneth | Director | 18 | $0 | $166.0K | 2025-10-07 |
| Ullman Anders | Director | 17 | $0 | $20.8K | 2025-10-07 |
| ACKERMANN CHRISTINA | Director | 16 | $198.5K | $361.4K | 2025-10-07 |
| Edwards Martin | Director | 19 | $62.1K | $165.7K | 2025-10-07 |
| ZACCARDELLI DAVID | President and CEO | 92 | $0 | $35.28M | 2025-10-07 |
| Hahn Mark W | Chief Financial Officer | 90 | $0 | $35.03M | 2025-10-07 |
| Sinha Vikas | Director | 33 | $0 | $3.18M | 2025-10-07 |
| SHAH MAHENDRA | Director | 18 | $0 | $67.1K | 2025-10-07 |
| EBSWORTH DAVID R | Director | 30 | $697.8K | $46.2K | 2025-10-07 |
| Poll Claire | General Counsel | 43 | $0 | $1.45M | 2024-02-01 |
| Gupta Rishi | Director | 12 | $0 | $145.94M | 2023-05-15 |
| ORBIMED ADVISORS LLC | Director | 4 | $0 | $9.94M | 2023-05-15 |
| OrbiMed Capital GP VI LLC | Director | 5 | $0 | $136.00M | 2022-12-23 |
| Blavatnik Len | 10% Owner | 1 | $6.29M | $0 | 2022-08-15 |
| Sinclair Andrew | Director | 1 | $0 | $0 | 2021-08-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| ACKERMANN CHRISTINA | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| ACKERMANN CHRISTINA | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 144,000 | — | $0 | 0 | SEC↗ |
| ACKERMANN CHRISTINA | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| Cunningham Kenneth | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| Cunningham Kenneth | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Cunningham Kenneth | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| Cunningham Kenneth | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| Cunningham Kenneth | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| Brady James Aloysius | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 288,000 | — | $0 | 0 | SEC↗ |
| Brady James Aloysius | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| Brady James Aloysius | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| Brady James Aloysius | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Edwards Martin | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| Edwards Martin | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Edwards Martin | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| Edwards Martin | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| Edwards Martin | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Deschamps Lisa | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| Deschamps Lisa | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| Deschamps Lisa | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| Deschamps Lisa | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| Deschamps Lisa | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 384 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| SHAH MAHENDRA | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| SHAH MAHENDRA | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| SHAH MAHENDRA | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| SHAH MAHENDRA | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| SHAH MAHENDRA | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Ullman Anders | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| Ullman Anders | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Ullman Anders | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| Ullman Anders | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| Ullman Anders | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| Austwick Michael | Director | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Austwick Michael | Director | D To issuer deriv | 2025-10-07 | 2025-10-08 | 144,000 | — | $0 | 0 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 445,536 | — | $0 | 0 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | A Award deriv | 2025-10-07 | 2025-10-08 | 1,649,952 | — | $0 | 1,649,952 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 1,649,952 | — | $0 | 0 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 389,792 | — | $0 | 0 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 800,000 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 167,056 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 146,168 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | D To issuer deriv | 2025-10-07 | 2025-10-08 | 100,000 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | D To issuer deriv | 2025-10-07 | 2025-10-08 | 560,000 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | A Award deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 618,760 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | A Award deriv | 2025-10-07 | 2025-10-08 | 1,649,952 | — | $0 | 1,649,952 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-10-07 | 2025-10-08 | 1,649,952 | — | $0 | 0 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-10-07 | 2025-10-08 | 445,536 | — | $0 | 0 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-10-07 | 2025-10-08 | 800,000 | — | $0 | 0 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-10-07 | 2025-10-08 | 389,792 | — | $0 | 0 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-10-07 | 2025-10-08 | 146,168 | — | $0 | 0 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-10-07 | 2025-10-08 | 167,056 | — | $0 | 0 | SEC↗ |
| Fisher Andrew | General Counsel | A Award deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 618,760 | SEC↗ |
| Fisher Andrew | General Counsel | D To issuer deriv | 2025-10-07 | 2025-10-08 | 2,240,000 | — | $0 | 0 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-10-07 | 2025-10-08 | 618,760 | — | $0 | 0 | SEC↗ |
| ACKERMANN CHRISTINA | Director | D To issuer | 2025-10-07 | 2025-10-08 | 64,072 | — | $0 | 0 | SEC↗ |
| ACKERMANN CHRISTINA | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| ACKERMANN CHRISTINA | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Cunningham Kenneth | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Cunningham Kenneth | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Cunningham Kenneth | Director | D To issuer | 2025-10-07 | 2025-10-08 | 79,776 | — | $0 | 0 | SEC↗ |
| Brady James Aloysius | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Brady James Aloysius | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Brady James Aloysius | Director | D To issuer | 2025-10-07 | 2025-10-08 | 23,176 | — | $0 | 0 | SEC↗ |
| Edwards Martin | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Edwards Martin | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Edwards Martin | Director | D To issuer | 2025-10-07 | 2025-10-08 | 157,992 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | D To issuer | 2025-10-07 | 2025-10-08 | 880,499 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | D To issuer | 2025-10-07 | 2025-10-08 | 617,600 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Deschamps Lisa | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Deschamps Lisa | Director | D To issuer | 2025-10-07 | 2025-10-08 | 84,856 | — | $0 | 0 | SEC↗ |
| Deschamps Lisa | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | D To issuer | 2025-10-07 | 2025-10-08 | 94,112 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| SHAH MAHENDRA | Director | D To issuer | 2025-10-07 | 2025-10-08 | 93,472 | — | $0 | 0 | SEC↗ |
| SHAH MAHENDRA | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| SHAH MAHENDRA | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Ullman Anders | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Ullman Anders | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Ullman Anders | Director | D To issuer | 2025-10-07 | 2025-10-08 | 358,856 | — | $0 | 0 | SEC↗ |
| Austwick Michael | Director | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| Austwick Michael | Director | D To issuer | 2025-10-07 | 2025-10-08 | 12,712 | — | $0 | 0 | SEC↗ |
| Austwick Michael | Director | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise | 2025-10-07 | 2025-10-08 | 3,285,280 | — | $0 | 3,285,280 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | D To issuer | 2025-10-07 | 2025-10-08 | 3,285,280 | — | $0 | 0 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | D To issuer | 2025-10-07 | 2025-10-08 | 11,264,968 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | D To issuer | 2025-10-07 | 2025-10-08 | 1,131,984 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | D To issuer | 2025-10-07 | 2025-10-08 | 2,432,868 | — | $0 | 0 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise | 2025-10-07 | 2025-10-08 | 1,131,984 | — | $0 | 1,131,984 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | D To issuer | 2025-10-07 | 2025-10-08 | 12,176,144 | — | $0 | 0 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise | 2025-10-07 | 2025-10-08 | 3,285,280 | — | $0 | 3,285,280 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | D To issuer | 2025-10-07 | 2025-10-08 | 3,285,280 | — | $0 | 0 | SEC↗ |
| Fisher Andrew | General Counsel | D To issuer | 2025-10-07 | 2025-10-08 | 931,984 | — | $0 | 0 | SEC↗ |
| Fisher Andrew | General Counsel | D To issuer | 2025-10-07 | 2025-10-08 | 417,903 | — | $0 | 0 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise | 2025-10-07 | 2025-10-08 | 931,984 | — | $0 | 931,984 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | G Gift | 2025-08-29 | 2025-09-03 | 1,200,000 | — | $0 | 11,264,968 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | G Gift | 2025-08-29 | 2025-09-03 | 189,600 | — | $0 | 2,417,872 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | G Gift | 2025-08-29 | 2025-09-03 | 1,200,000 | — | $0 | 12,176,144 | SEC↗ |
| Ullman Anders | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Sinha Vikas | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| SHAH MAHENDRA | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Edwards Martin | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-08-01 | 2025-08-05 | 200,000 | — | $0 | 800,000 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-08-01 | 2025-08-05 | 55,696 | — | $0 | 389,792 | SEC↗ |
| Brady James Aloysius | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Austwick Michael | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| ACKERMANN CHRISTINA | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-08-01 | 2025-08-05 | 50,000 | — | $0 | 200,000 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-08-01 | 2025-08-05 | 20,888 | — | $0 | 146,168 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-08-01 | 2025-08-05 | 200,000 | — | $0 | 800,000 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-08-01 | 2025-08-05 | 55,696 | — | $0 | 389,792 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-08-01 | 2025-08-05 | 20,888 | — | $0 | 146,168 | SEC↗ |
| Deschamps Lisa | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Cunningham Kenneth | Director | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Ullman Anders | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 358,856 | SEC↗ |
| Sinha Vikas | Director | S Sale | 2025-08-01 | 2025-08-05 | 4,328 | $13.14 | $56.9K | 94,112 | SEC↗ |
| Sinha Vikas | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 98,440 | SEC↗ |
| SHAH MAHENDRA | Director | S Sale | 2025-08-01 | 2025-08-05 | 3,608 | $13.14 | $47.4K | 93,472 | SEC↗ |
| SHAH MAHENDRA | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 97,080 | SEC↗ |
| Edwards Martin | Director | S Sale | 2025-08-01 | 2025-08-05 | 10,808 | $13.14 | $142.0K | 157,992 | SEC↗ |
| Edwards Martin | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 168,800 | SEC↗ |
| EBSWORTH DAVID R | Director | S Sale | 2025-08-01 | 2025-08-05 | 1,904 | $13.14 | $25.0K | 880,499 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 882,403 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise | 2025-08-01 | 2025-08-05 | 255,696 | — | $0 | 13,585,056 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-08-01 | 2025-08-05 | 208,912 | $13.14 | $2.75M | 13,376,144 | SEC↗ |
| Brady James Aloysius | Director | S Sale | 2025-08-01 | 2025-08-05 | 824 | $13.14 | $10.8K | 23,176 | SEC↗ |
| Brady James Aloysius | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Austwick Michael | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Austwick Michael | Director | S Sale | 2025-08-01 | 2025-08-05 | 11,288 | $13.14 | $148.3K | 12,712 | SEC↗ |
| ACKERMANN CHRISTINA | Director | S Sale | 2025-08-01 | 2025-08-05 | 1,808 | $13.14 | $23.8K | 64,072 | SEC↗ |
| ACKERMANN CHRISTINA | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 65,880 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise | 2025-08-01 | 2025-08-05 | 70,888 | — | $0 | 2,665,808 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | S Sale | 2025-08-01 | 2025-08-05 | 58,336 | $13.14 | $766.5K | 2,607,472 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise | 2025-08-01 | 2025-08-05 | 255,696 | — | $0 | 12,673,880 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-08-01 | 2025-08-05 | 208,912 | $13.14 | $2.75M | 12,464,968 | SEC↗ |
| Fisher Andrew | General Counsel | S Sale | 2025-08-01 | 2025-08-05 | 9,584 | $13.14 | $125.9K | 417,903 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise | 2025-08-01 | 2025-08-05 | 20,888 | — | $0 | 427,487 | SEC↗ |
| Deschamps Lisa | Director | S Sale | 2025-08-01 | 2025-08-05 | 9,464 | $13.14 | $124.4K | 84,856 | SEC↗ |
| Deschamps Lisa | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 94,320 | SEC↗ |
| Cunningham Kenneth | Director | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 90,584 | SEC↗ |
| Cunningham Kenneth | Director | S Sale | 2025-08-01 | 2025-08-05 | 10,808 | $13.14 | $142.0K | 79,776 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | F Tax w/h | 2025-07-08 | 2025-07-09 | 90,320 | $11.44 | $1.03M | 13,329,360 | SEC↗ |
| Fisher Andrew | General Counsel | F Tax w/h | 2025-07-08 | 2025-07-09 | 39,464 | $11.44 | $451.5K | 406,599 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | F Tax w/h | 2025-07-08 | 2025-07-09 | 37,616 | $11.44 | $430.3K | 2,594,920 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | F Tax w/h | 2025-07-08 | 2025-07-09 | 90,320 | $11.44 | $1.03M | 12,418,184 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-07-07 | 2025-07-09 | 229,512 | — | $0 | 445,536 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | A Award deriv | 2025-07-07 | 2025-07-09 | 675,048 | — | $0 | 675,048 | SEC↗ |
| Fisher Andrew | General Counsel | A Award deriv | 2025-07-07 | 2025-07-09 | 253,120 | — | $0 | 253,120 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 167,056 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | A Award deriv | 2025-07-07 | 2025-07-09 | 253,120 | — | $0 | 253,120 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 167,056 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-07-07 | 2025-07-09 | 229,512 | — | $0 | 445,536 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | A Award deriv | 2025-07-07 | 2025-07-09 | 675,048 | — | $0 | 675,048 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise | 2025-07-07 | 2025-07-09 | 229,512 | — | $0 | 13,419,680 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 446,063 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise | 2025-07-07 | 2025-07-09 | 86,064 | — | $0 | 2,632,536 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise | 2025-07-07 | 2025-07-09 | 229,512 | — | $0 | 12,508,504 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-06-16 | 2025-06-18 | 80,000 | — | $0 | 2,240,000 | SEC↗ |
| Fisher Andrew | General Counsel | S Sale | 2025-06-16 | 2025-06-18 | 80,000 | $11.53 | $922.4K | 359,999 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise | 2025-06-16 | 2025-06-18 | 80,000 | $2.01 | $160.8K | 439,999 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-06-11 | 2025-06-13 | 400,000 | $11.40 | $4.56M | 13,190,168 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-06-11 | 2025-06-13 | 400,000 | $11.40 | $4.56M | 12,278,992 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-05-29 | 2025-05-29 | 208,696 | $9.33 | $1.95M | 13,590,168 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-05-29 | 2025-05-29 | 204,864 | $9.33 | $1.91M | 12,678,992 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-05-28 | 2025-05-29 | 157,704 | $9.30 | $1.47M | 13,798,864 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-05-28 | 2025-05-29 | 162,704 | $9.30 | $1.51M | 12,883,856 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-05-27 | 2025-05-29 | 33,600 | $9.53 | $320.2K | 13,956,568 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-05-27 | 2025-05-29 | 32,432 | $9.53 | $309.1K | 13,046,560 | SEC↗ |
| Sinha Vikas | Director | M Exercise deriv | 2025-05-20 | 2025-05-22 | 160,000 | — | $0 | 384 | SEC↗ |
| Sinha Vikas | Director | M Exercise | 2025-05-20 | 2025-05-22 | 160,000 | $0.50 | $80.0K | 234,440 | SEC↗ |
| Sinha Vikas | Director | S Sale | 2025-05-20 | 2025-05-22 | 160,000 | $9.39 | $1.50M | 74,440 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-05-15 | 2025-05-16 | 80,000 | — | $0 | 2,320,000 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-05-15 | 2025-06-18 | 80,000 | — | $0 | 2,320,000 | SEC↗ |
| Fisher Andrew | General Counsel | S Sale | 2025-05-15 | 2025-05-16 | 80,000 | $8.57 | $685.6K | 359,999 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise | 2025-05-15 | 2025-05-16 | 80,000 | $2.11 | $168.8K | 439,999 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise | 2025-05-15 | 2025-06-18 | 80,000 | $2.01 | $160.8K | 439,999 | SEC↗ |
| ACKERMANN CHRISTINA | Director | M Exercise deriv | 2025-05-14 | 2025-05-16 | 40,000 | — | $0 | 200,000 | SEC↗ |
| ACKERMANN CHRISTINA | Director | M Exercise | 2025-05-14 | 2025-05-16 | 40,000 | $1.93 | $77.2K | 81,880 | SEC↗ |
| ACKERMANN CHRISTINA | Director | S Sale | 2025-05-14 | 2025-05-16 | 40,000 | $8.44 | $337.6K | 41,880 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | S Sale | 2025-05-06 | 2025-05-08 | 114,984 | $8.82 | $1.01M | 2,546,472 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-05-02 | 2025-05-05 | 400,000 | $9.09 | $3.64M | 13,990,168 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-05-02 | 2025-05-05 | 400,000 | $9.09 | $3.64M | 13,078,992 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-05-01 | 2025-05-05 | 200,000 | — | $0 | 1,000,000 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise deriv | 2025-05-01 | 2025-05-05 | 140,000 | — | $0 | 0 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-05-01 | 2025-05-05 | 200,000 | — | $0 | 1,000,000 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-05-01 | 2025-05-05 | 50,000 | — | $0 | 250,000 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-05-01 | 2025-05-05 | 108,272 | $8.95 | $969.0K | 14,268,904 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-05-01 | 2025-05-05 | 78,736 | $8.95 | $704.7K | 14,390,168 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise | 2025-05-01 | 2025-05-05 | 200,000 | — | $0 | 14,468,904 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise | 2025-05-01 | 2025-05-05 | 140,000 | $1.93 | $270.2K | 1,476,003 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-05-01 | 2025-05-05 | 108,272 | $8.95 | $969.0K | 13,357,728 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-05-01 | 2025-05-05 | 78,736 | $8.95 | $704.7K | 13,478,992 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise | 2025-05-01 | 2025-05-05 | 200,000 | — | $0 | 13,557,728 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | S Sale | 2025-05-01 | 2025-05-05 | 21,864 | $8.95 | $195.7K | 2,661,456 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | S Sale | 2025-05-01 | 2025-05-05 | 27,336 | $8.95 | $244.7K | 2,633,320 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise | 2025-05-01 | 2025-05-05 | 50,000 | — | $0 | 2,683,320 | SEC↗ |
| Sinha Vikas | Director | M Exercise deriv | 2025-04-29 | 2025-05-01 | 4,952 | — | $0 | 195,048 | SEC↗ |
| Sinha Vikas | Director | M Exercise deriv | 2025-04-29 | 2025-05-01 | 15,048 | — | $0 | 80,952 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise deriv | 2025-04-29 | 2025-05-01 | 229,512 | — | $0 | 445,488 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | A Award deriv | 2025-04-29 | 2025-05-01 | 675,000 | — | $0 | 675,000 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | A Award deriv | 2025-04-29 | 2025-05-01 | 253,120 | — | $0 | 253,120 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise deriv | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 167,056 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | A Award deriv | 2025-04-29 | 2025-05-01 | 675,000 | — | $0 | 675,000 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise deriv | 2025-04-29 | 2025-05-01 | 229,512 | — | $0 | 445,488 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise deriv | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 167,056 | SEC↗ |
| Fisher Andrew | General Counsel | A Award deriv | 2025-04-29 | 2025-05-01 | 253,120 | — | $0 | 253,120 | SEC↗ |
| Sinha Vikas | Director | M Exercise deriv | 2025-04-29 | 2025-05-22 | 120,384 | — | $0 | 0 | SEC↗ |
| Sinha Vikas | Director | M Exercise deriv | 2025-04-29 | 2025-05-22 | 39,616 | — | $0 | 160,384 | SEC↗ |
| Sinha Vikas | Director | M Exercise | 2025-04-29 | 2025-05-01 | 15,048 | $1.70 | $25.6K | 89,488 | SEC↗ |
| Sinha Vikas | Director | M Exercise | 2025-04-29 | 2025-05-01 | 4,952 | $0.50 | $2.5K | 79,392 | SEC↗ |
| Sinha Vikas | Director | S Sale | 2025-04-29 | 2025-05-01 | 15,048 | $8.92 | $134.2K | 74,440 | SEC↗ |
| Sinha Vikas | Director | S Sale | 2025-04-29 | 2025-05-01 | 4,952 | $8.92 | $44.2K | 74,440 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2025-04-29 | 2025-05-01 | 90,360 | $8.98 | $811.4K | 13,466,000 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | M Exercise | 2025-04-29 | 2025-05-01 | 229,512 | — | $0 | 13,556,360 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | S Sale | 2025-04-29 | 2025-05-01 | 34,384 | $8.98 | $308.8K | 2,660,656 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | M Exercise | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 2,695,040 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | M Exercise | 2025-04-29 | 2025-05-01 | 229,512 | — | $0 | 14,467,536 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2025-04-29 | 2025-05-01 | 90,360 | $8.98 | $811.4K | 14,377,176 | SEC↗ |
| Fisher Andrew | General Counsel | S Sale | 2025-04-29 | 2025-05-01 | 26,072 | $8.98 | $234.1K | 359,993 | SEC↗ |
| Fisher Andrew | General Counsel | M Exercise | 2025-04-29 | 2025-05-01 | 86,064 | — | $0 | 386,065 | SEC↗ |
| Sinha Vikas | Director | M Exercise | 2025-04-29 | 2025-05-22 | 39,616 | $0.50 | $19.8K | 114,056 | SEC↗ |
| Sinha Vikas | Director | M Exercise | 2025-04-29 | 2025-05-22 | 120,384 | $1.70 | $204.7K | 194,824 | SEC↗ |
| Sinha Vikas | Director | S Sale | 2025-04-29 | 2025-05-22 | 120,384 | $8.92 | $1.07M | 74,440 | SEC↗ |
| Sinha Vikas | Director | S Sale | 2025-04-29 | 2025-05-22 | 39,616 | $8.92 | $353.4K | 74,440 | SEC↗ |
| ACKERMANN CHRISTINA | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Brady James Aloysius | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Austwick Michael | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Cunningham Kenneth | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Deschamps Lisa | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Edwards Martin | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| SHAH MAHENDRA | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Sinha Vikas | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Ullman Anders | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| EBSWORTH DAVID R | Director | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Fisher Andrew | General Counsel | G Gift | 2025-03-19 | 2025-05-01 | 1 | — | $0 | 300,001 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | S Sale | 2025-03-12 | 2025-03-13 | 79,264 | $8.35 | $661.9K | 2,608,976 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise deriv | 2025-02-26 | 2025-02-28 | 64,000 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise deriv | 2025-02-26 | 2025-02-28 | 200,000 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise deriv | 2025-02-26 | 2025-02-28 | 100,000 | — | $0 | 140,000 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise deriv | 2025-02-26 | 2025-02-28 | 96,000 | — | $0 | 0 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise | 2025-02-26 | 2025-02-28 | 96,000 | $2.67 | $256.3K | 1,300,003 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise | 2025-02-26 | 2025-02-28 | 64,000 | $0.78 | $49.9K | 1,004,003 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise | 2025-02-26 | 2025-02-28 | 200,000 | $0.50 | $100.0K | 1,204,003 | SEC↗ |
| EBSWORTH DAVID R | Director | G Gift | 2025-02-26 | 2025-02-28 | 64,000 | — | $0 | 1,336,003 | SEC↗ |
| EBSWORTH DAVID R | Director | M Exercise | 2025-02-26 | 2025-02-28 | 100,000 | $1.93 | $193.0K | 1,400,003 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | F Tax w/h | 2025-02-03 | 2025-02-04 | 33,240 | $7.16 | $238.0K | 2,688,240 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | F Tax w/h | 2025-02-03 | 2025-02-04 | 166,888 | $7.16 | $1.19M | 13,326,848 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | F Tax w/h | 2025-02-03 | 2025-02-04 | 166,728 | $7.16 | $1.19M | 14,238,024 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | A Award | 2025-02-01 | 2025-02-04 | 50,000 | — | $0 | 2,721,480 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | A Award | 2025-02-01 | 2025-02-04 | 200,000 | — | $0 | 13,493,736 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | A Award | 2025-02-01 | 2025-02-04 | 200,000 | — | $0 | 14,404,752 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-12-06 | 2024-12-06 | 183,728 | $5.01 | $920.5K | 13,293,736 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-12-06 | 2024-12-06 | 162,800 | $5.01 | $815.6K | 14,204,752 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-12-05 | 2024-12-06 | 640,048 | $5.01 | $3.21M | 13,477,464 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-12-05 | 2024-12-06 | 640,264 | $5.01 | $3.21M | 14,367,552 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-12-04 | 2024-12-06 | 58,184 | $5.00 | $290.9K | 14,117,512 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-12-04 | 2024-12-06 | 67,608 | $5.00 | $338.0K | 15,007,816 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-12-02 | 2024-12-02 | 3,200 | $5.00 | $16.0K | 15,075,424 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-12-02 | 2024-12-02 | 1,600 | $5.00 | $8.0K | 14,175,696 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-11-29 | 2024-12-02 | 98,888 | $5.01 | $495.4K | 15,078,624 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-11-29 | 2024-12-02 | 98,704 | $5.01 | $494.5K | 14,177,296 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-11-27 | 2024-12-02 | 23,240 | $5.00 | $116.2K | 15,177,512 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-11-27 | 2024-12-02 | 12,936 | $5.00 | $64.7K | 14,276,000 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-11-26 | 2024-11-26 | 800 | $5.00 | $4.0K | 14,288,936 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | S Sale | 2024-11-25 | 2024-11-26 | 240,000 | $4.90 | $1.18M | 2,671,480 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-11-25 | 2024-11-26 | 1,600 | $5.00 | $8.0K | 15,200,752 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-11-25 | 2024-11-26 | 1,600 | $5.00 | $8.0K | 14,289,736 | SEC↗ |
| EBSWORTH DAVID R | Director | P Buy | 2024-11-18 | 2024-11-18 | 20,000 | $4.44 | $88.8K | 940,003 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-11-11 | 2024-11-13 | 2,400 | $5.00 | $12.0K | 14,291,336 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-11-11 | 2024-11-13 | 2,400 | $5.00 | $12.0K | 15,202,352 | SEC↗ |
| ACKERMANN CHRISTINA | Director | P Buy | 2024-11-06 | 2024-11-07 | 41,880 | $4.74 | $198.5K | 41,880 | SEC↗ |
| EBSWORTH DAVID R | Director | P Buy | 2024-11-06 | 2024-11-07 | 39,360 | $4.80 | $188.9K | 920,003 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-11-04 | 2024-11-05 | 80,784 | $4.39 | $354.6K | 14,293,736 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-11-04 | 2024-11-05 | 94,144 | $4.39 | $413.3K | 15,204,752 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | A Award | 2024-11-01 | 2024-11-01 | 200,000 | — | $0 | 14,669,360 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | F Tax w/h | 2024-11-01 | 2024-11-01 | 245,952 | $4.24 | $1.04M | 14,423,408 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | A Award | 2024-11-01 | 2024-11-01 | 50,000 | — | $0 | 2,977,416 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | F Tax w/h | 2024-11-01 | 2024-11-01 | 65,936 | $4.24 | $279.6K | 2,911,480 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | F Tax w/h | 2024-11-01 | 2024-11-01 | 245,952 | $4.24 | $1.04M | 15,345,784 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | A Award | 2024-11-01 | 2024-11-01 | 200,000 | — | $0 | 15,591,736 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-11-01 | 2024-11-05 | 48,888 | $4.38 | $214.1K | 14,374,520 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-11-01 | 2024-11-05 | 46,888 | $4.38 | $205.4K | 15,298,896 | SEC↗ |
| Fisher Andrew | General Counsel | A Award | 2024-10-30 | 2024-11-01 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | A Award | 2024-10-30 | 2024-11-01 | 800,000 | — | $0 | 14,469,360 | SEC↗ |
| Rickard Kathleen A. | Chief Medical Officer | A Award | 2024-10-30 | 2024-11-01 | 300,000 | — | $0 | 2,927,416 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | A Award | 2024-10-30 | 2024-11-01 | 800,000 | — | $0 | 15,391,736 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-10-25 | 2024-10-25 | 4,800 | $4.38 | $21.0K | 14,591,736 | SEC↗ |
| Hahn Mark W | Chief Financial Officer | S Sale | 2024-10-25 | 2024-10-25 | 3,200 | $4.38 | $14.0K | 13,669,360 | SEC↗ |
| ZACCARDELLI DAVID | President and CEO | S Sale | 2024-10-24 | 2024-10-25 | 140,000 | $4.38 | $613.2K | 14,596,536 | SEC↗ |